JPMorgan says this biotech stock can more than double following steep declines
The investment bank initiated coverage with an overweight rating.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
More in Finance & Markets
GST Council scraps tax officers' arrest powers; prosecution threshold raised to Rs 5 cr
The GST Council made a landmark decision by abolishing the arrest powers of tax officers. They've raised the prosecution threshold from Rs 1 crore to Rs 5 crore, easing the pressure on small sellers…
Tror norsk bank skuffer
Bank of America gjentar salgsanbefaling for norsk storbank før kvartalstall. Kun én nordisk bank anbefales.
Stock Market Crash: Why Are Sensex & Nifty Bleeding, 5 Big Fears Behind The Massive Sell-Off Explained
Mumbai: Indian stock markets are facing intense selling pressure, with benchmark indices Sensex and Nifty falling sharply as investors struggle with rising economic uncertainty.
Canadian Dollar nears 18-month lows as risk aversion buoys the US Dollar
The Canadian Dollar (CAD) posts marginal losses on Thursday with the safe-haven US Dollar (USD) favoured by the risk-averse mood, as tensions in the Middle East boost Crude prices and the global bond…
Climate shocks threaten Africa’s growth as 140m need food aid — WorldBank
Climate-related shocks are threatening to weaken economic growth, worsen food insecurity and deepen fiscal pressures across Sub-Saharan Africa, with nearly